I agree & Ive seen it. I've worked in pharma for over 20 years. If approval came in EU first, US might follow. I've seen that before on the flip side concerning import bans. I haven't been paying close attention here.. "Address steps required"... I thought they flat out said it wasn't approved for efficacy? It had something to do with the way they filed? TY
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.